ClinicalTrials.gg
RecruitingNCT05986032REACTUpdated Mar 6, 2024

Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia

An observational study in Bronchopulmonary Dysplasia, sponsored by Fondazione IRCCS San Gerardo dei Tintori. Recruiting at 6 sites in 5 countries. Open to participants aged 5 Days to 9 Days. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by Fondazione IRCCS San Gerardo dei Tintori · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
150
Ages
5 Days to 9 Days
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Bronchopulmonary Dysplasia with a site in Italy — 6 open to participants now, 8 under way, 1 of them phase 3. Bronchopulmonary Dysplasia · Italy.

Started
2023
with 2 others
Observational
4 of 16
2 open now
Registered
12th of 16
by date
Lead sponsor
1 of 16
Fondazione IRCCS San Gerardo dei Tintori

Among the 16 studies in Bronchopulmonary Dysplasia with a site in Italy, this one is one of 3 that started in 2023, is one of 4 observational ones, and was the 12th registered.

Bronchopulmonary Dysplasia

363 studies on the registry are indexed under Bronchopulmonary Dysplasia; 85 are open to participants now.

Browse Bronchopulmonary Dysplasia studies →

Open to participants now

6 of the 16 studies in Bronchopulmonary Dysplasia with a site in Italy are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 57 Bronchopulmonary Dysplasia studies recruiting now, 6 (11%) set no upper age limit and 50 (88%) stop at 75 or younger; 55 take children under 18; 11 take healthy volunteers.

This study: 5 Days to 9 Days · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Bronchopulmonary Dysplasia with a site in Italy, or all of them as a file.
02

Study summary

The goal of this observational study is to learn about the correlation between respiratory system reactance, as assessed by respiratory oscillometry, and respiratory outcomes in preterm infants born before 32 weeks of gestation. The main question it aims to answer is if the reactance z-score at 7 postnatal days adds to relevant clinical factors in the prediction of bronchopulmonary dysplasia. Participants will receive respiratory oscillometry measurements at 7 ± 2 postnatal days.

03

Conditions studied

  • Bronchopulmonary Dysplasia

Keywords

  • Respiratory oscillometry
  • Respiratory system reactance
  • Lung mechanics
  • Infant lung function testing
04

Who can participate

Ages eligible
5 Days to 9 Days
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Infants will be recruited from those admitted to tertiary-level neonatal intensive care units.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • born before 32 weeks post-menstrual age

Exclusion criteria

Exclusion Criteria:

  • congenital abnormalities
  • Inherited disorders of metabolism
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • no bronchopulmonary dysplasia

    Group of patients who do not receive the diagnosis of bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-mentrual age

    Diagnostic Test: Respiratory Oscillometry

  • bronchopulmonary dysplasia

    Group of patients developing bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-menstrual age.

    Diagnostic Test: Respiratory Oscillometry

Interventions

  • Diagnostic testRespiratory Oscillometry

    Measurement of respiratory system reactance by respiratory oscillometry

06

What researchers measure

Primary outcomes

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure

    Xrs will be expressed in z-score using reference equation for very preterm infants

    Time frame: Xrs will be measured at 7 days of life

Secondary outcomes

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure and ± 2 cmH2O

    Xrs will be expressed in cmH2O\*S/L

    Time frame: Xrs will be measured at 7 days of life

Other outcomes

  1. Respiratory support mode

    Respiratory support mode will be coded as 0 = no respiratory support, 1 = nasal high flow therapy, 2 = nasal CPAP or nasal IPPV, 3 = invasive mechanical ventilation

    Time frame: 7 postnatal days

  2. Fraction of inspired oxygen

    Time frame: 7 days of life

07

Study locations

6 of 6 sites recruiting
08

References and documents

Publications

  • Zannin E, Neumann RP, Dellaca R, Schulzke SM. Forced oscillation measurements in the first week of life and pulmonary outcome in very preterm infants on noninvasive respiratory support. Pediatr Res. 2019 Sep;86(3):382-388. doi: 10.1038/s41390-019-0432-6. Epub 2019 May 20. PubMed 31108499 ↗
  • Veneroni C, Wallstrom L, Sindelar R, Dellaca' RL. Oscillatory respiratory mechanics on the first day of life improves prediction of respiratory outcomes in extremely preterm newborns. Pediatr Res. 2019 Feb;85(3):312-317. doi: 10.1038/s41390-018-0133-6. Epub 2018 Aug 4. PubMed 30127523 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2023 (actual). Primary completion is estimated for Sep 2024, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2023
First posted
Aug 14, 2023
StartActual
Jul 15, 2023
Primary completionEst.
Sep 3, 2024
CompletionEst.
Sep 24, 2024
Last update
Mar 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05986032
Lead sponsor
Fondazione IRCCS San Gerardo dei Tintori
Collaborators
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University Children's Hospital Basel, Uppsala University Hospital, Medical University of Vienna, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Responsible party
Sponsor
First posted
Aug 14, 2023
Start date
Jul 15, 2023
Primary completion
Sep 3, 2024 (estimated)
Completion
Sep 24, 2024 (estimated)
Last update
Mar 6, 2024

Study contacts

Camilla Rigotti, PhD
Contact
dr.camilla.rigotti@gmail.com
+39039233 ext. 9173
Emanuela Zannin, PhD
Contact
emanuela.zannin@gmail.com
+393389323437
Camilla Rigotti, PhD
principal investigator · Fondazione IRCCS San Gerardo dei Tintori
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion